Development and validation of a prediction model for active tuberculosis case finding among HIV-negative/unknown populations.

Sci Rep 2019 Apr 16;9(1):6143. Epub 2019 Apr 16.

Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.

A prediction model of prevalent pulmonary tuberculosis (TB) in HIV negative/unknown individuals was developed to assist systematic screening. Data from a large TB screening trial were used. A multivariable logistic regression model was developed in the South African (SA) training dataset, using TB symptoms and risk factors as predictors. The model was converted into a scoring system for risk stratification and was evaluated in separate SA and Zambian validation datasets. The number of TB cases were 355, 176, and 107 in the SA training, SA validation, and Zambian validation datasets respectively. The area under curve (AUC) of the scoring system was 0·68 (95% CI 0·64-0·72) in the SA validation set, compared to prolonged cough (0·58, 95% CI 0·54-0·62) and any TB symptoms (0·6, 95% CI 0·56-0·64). In the Zambian dataset the AUC of the scoring system was 0·66 (95% CI 0·60-0·72). In the cost-effectiveness analysis, the scoring system dominated the conventional strategies. The cost per TB case detected ranged from 429 to 1,848 USD in the SA validation set and from 171 to 10,518 USD in the Zambian dataset. The scoring system may help targeted TB case finding under budget constraints.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-42372-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467872PMC
April 2019
4 Reads

Publication Analysis

Top Keywords

scoring system
20
case finding
8
validation datasets
8
zambian validation
8
auc scoring
8
zambian dataset
8
validation set
8
prediction model
8
system
5
validation
5
scoring
5
0·68 95%
4
converted scoring
4
system risk
4
model converted
4
stratification evaluated
4
95% 0·56-0·64
4
risk stratification
4
detected ranged
4
ranged 429
4

References

(Supplied by CrossRef)

M Claassens et al.
PLoS One. 2013

JE Golub et al.
Int J Tuberc Lung Dis. 2005

SS Wyk Van et al.
Int J Tuberc Lung Dis. 2017

HM Ayles et al.
Trials. 2008

C Sismanidis et al.
Clin Trials. 2008

MJ Reid et al.
Lancet Infect Dis. 2009

KG Moons et al.
Ann Intern Med. 2015

Similar Publications